|
Delaware
|
| |
6770
|
| |
87-1431377
|
|
|
(State or other jurisdiction of
incorporation or organization) |
| |
(Primary Standard Industrial
Classification Code Number) |
| |
(I.R.S. Employer Identification
Number) |
|
|
Will Chuchawat
Daniel Forman Anh Tran Proskauer Rose LLP 2029 Century Park East, Suite 2400 Los Angeles, CA 90067 (310) 284-4550 |
| |
Douglas V. Getten
Travis J. Wofford Baker Botts LLP 910 Louisiana Street Houston, TX 77002-4995 (713) 229-1234 |
|
|
Large accelerated filer
☐
|
| |
Accelerated filer
☐
|
|
|
Non-accelerated filer
☒
|
| |
Smaller reporting company
☒
|
|
| | | |
Emerging growth company
☒
|
|
| | ||||||||||||||||
Title of each Class of Security being registered
|
| | |
Amount being
Registered |
| | |
Proposed
Maximum Offering Price Per Security(1) |
| | |
Proposed
Maximum Aggregate Offering Price(1) |
| | |
Amount of
Registration Fee |
|
Units, each consisting of one share of Class A common stock, $.0001 par value, and one-half of one Redeemable Warrant(2)
|
| | |
23,000,000 Units
|
| | |
$10.00
|
| | |
$230,000,000
|
| | |
$21,321.00
|
|
Shares of Class A common stock included as part of the Units(3)
|
| | |
23,000,000 Shares
|
| | | | | | | | | | |
—(4)
|
|
Redeemable Warrants included as part of the Units(3)
|
| | |
11,500,000 Warrants
|
| | | | | | | | | | |
—(4)
|
|
Shares underlying
Redeemable Warrants included as part of the Units |
| | |
11,500,000 Shares
|
| | |
$11.50
|
| | |
$132,250,000
|
| | |
12,259.58
|
|
Total
|
| | | | | | | | | | |
$362,250,000
|
| | |
$33,580.58(5)
|
|
|
SEC expenses
|
| | | $ | 33,581 | | |
|
FINRA expenses
|
| | | | 54,838 | | |
|
Accounting fees and expenses
|
| | | | 85,000 | | |
|
Printing expenses
|
| | | | 15,000 | | |
|
Issuer legal fees and expenses
|
| | | | 300,000 | | |
|
Nasdaq listing fees
|
| | | | 75,000 | | |
|
Underwriter legal and roadshow expenses
|
| | | | 150,000 | | |
|
Miscellaneous expenses
|
| | | | 86,581 | | |
|
Total
|
| | | $ | 800,000 | | |
|
Exhibit No.
|
| |
Description
|
|
| 1.1 | | | Form of Underwriting Agreement.* | |
| 3.1 | | | | |
| 3.2 | | | | |
| 3.3 | | | | |
| 4.1 | | | | |
| 4.2 | | | | |
| 4.3 | | | | |
| 4.4 | | | | |
| 5.1 | | | | |
| 10.1 | | | | |
| 10.2 | | | | |
| 10.3 | | | | |
| 10.4 | | | | |
| 10.5 | | | |
|
Exhibit No.
|
| |
Description
|
|
| 10.6 | | | | |
| 14 | | | | |
| 23.1 | | | | |
| 23.2 | | | | |
| 24 | | | | |
| 99.1 | | | | |
| 99.2 | | | | |
| 99.3 | | | |
|
Name
|
| |
Position
|
| |
Date
|
|
|
/s/ Aaron T. Ratner
Aaron T. Ratner
|
| |
Chief Executive Officer
(Principal Executive Officer) |
| |
December 8, 2021
|
|
|
/s/ Martha F. Ross
Martha F. Ross
|
| |
Chief Financial Officer and Chief Operating Officer (Principal Financial and Accounting Officer)
|
| |
December 8, 2021
|
|
|
*
Nicholas Parker
|
| |
Executive Chairman and Director
|
| |
December 8, 2021
|
|
|
*
Candice Beaumont
|
| |
Director
|
| |
December 8, 2021
|
|
|
*
Bradford Allen
|
| |
Director
|
| |
December 8, 2021
|
|
|
*
Michael R. Vahrenkamp
|
| |
Director
|
| |
December 8, 2021
|
|
|
/s/ Aaron T. Ratner
Aaron Ratner
Attorney-in-Fact |
| | | |